Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong – Darmstadt): Complete Statistical AnalysisIndependent statistical analysis of Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03566810).
- Glucose Regulation in Acute Stroke Patients (GRASP) Study: Complete Statistical AnalysisIndependent statistical analysis of Glucose Regulation in Acute Stroke Patients (GRASP) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00282867).
- Glucose Variability in Type 1 Diabetes (T1D) and Glycaemic Responses to Food Composition.: Complete Statistical AnalysisIndependent statistical analysis of Glucose Variability in Type 1 Diabetes (T1D) and Glycaemic Responses to Food Composition.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GlulipidIndependent statistical analysis of Glucose and Lipid Metabolism on Antipsychotic Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515723).
- GLUMIT-DGIndependent statistical analysis of Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030341).
- Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy: Complete Statistical AnalysisIndependent statistical analysis of Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Glutathione Metabolism in Adolescents With Type 1 Diabetes – Study A: Complete Statistical AnalysisIndependent statistical analysis of Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size…
- GMRTIndependent statistical analysis of Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01726036).
- GMTIndependent statistical analysis of Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02486263).
- GO-COLITISIndependent statistical analysis of Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02092285).
- GO-VIVAIndependent statistical analysis of A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: primary endpoint results,…
- GO2 PEEPIndependent statistical analysis of Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA): Complete Statistical AnalysisIndependent statistical analysis of Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GOLMePsAIndependent statistical analysis of GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04108468).
- GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): Complete Statistical AnalysisIndependent statistical analysis of GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04706273).
- Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers: Complete Statistical AnalysisIndependent statistical analysis of Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GQ01Independent statistical analysis of The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- GRABM-LIndependent statistical analysis of GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.: Complete Statistical AnalysisIndependent statistical analysis of GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV)…
- GRAMSIndependent statistical analysis of Gadobutrol Enhanced MRA of the Renal Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01344460).
- GRAND-307Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes: primary endpoint results, effect estimate with…
- Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GRAVITYIndependent statistical analysis of 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GRAY-BIndependent statistical analysis of GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065): Complete Statistical AnalysisIndependent statistical analysis of Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GRC00097Independent statistical analysis of Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively: primary endpoint results, effect estimate with…
- GReaTIndependent statistical analysis of Gene Regulation by Thiazolidinediones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00567593).
- GREATIndependent statistical analysis of Get Ready And Empowered About Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165735).
- Greater Occipital Nerve Block Versus Metoclopramide: Complete Statistical AnalysisIndependent statistical analysis of Greater Occipital Nerve Block Versus Metoclopramide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03269435).
- GRECOIndependent statistical analysis of Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Green Tea and Reduction of Breast Cancer Risk: Complete Statistical AnalysisIndependent statistical analysis of Green Tea and Reduction of Breast Cancer Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00917735).
- Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GreenLight XPS Laser System Retrospective Chart Review: Complete Statistical AnalysisIndependent statistical analysis of GreenLight XPS Laser System Retrospective Chart Review: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139969).
- GRINIndependent statistical analysis of Testing Preliminary Effectiveness of a Training to Support CHWs Outreach on Dental to African American Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings: Complete Statistical AnalysisIndependent statistical analysis of Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism: Complete Statistical AnalysisIndependent statistical analysis of Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206375).
- Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance: Complete Statistical AnalysisIndependent statistical analysis of Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Growth-TBIIndependent statistical analysis of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00766038).
- GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GSK1120212+GSK2141795 for Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212+GSK2141795 for Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01958112).
- GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia: Complete Statistical AnalysisIndependent statistical analysis of GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia: primary endpoint results, effect estimate…
- GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00950807).
- guardian™ 3Independent statistical analysis of Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GUIDE-ITIndependent statistical analysis of Guiding Evidence Based Therapy Using Biomarker Intensified Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01685840).
- GUIDEDIndependent statistical analysis of Genomics Used to Improve DEpression Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02109939).
- GuidePathIndependent statistical analysis of Study of Diagnostic Performance of [18F]CTT1057 in BCR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04838613).
- Gulf War Digestive Health Study: Complete Statistical AnalysisIndependent statistical analysis of Gulf War Digestive Health Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680836).
- gustinpropIndependent statistical analysis of Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01097915).